Development and validation of NTCP models for acute side-effects resulting from proton beam therapy of brain tumours.

[1]  B. S. Sørensen,et al.  "Radiobiology of Proton Therapy": Results of an international expert workshop. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  C. Simone,et al.  Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review , 2018, Journal of the National Cancer Institute.

[3]  A. Lühr,et al.  Relative biological effectiveness in proton beam therapy – Current knowledge and future challenges , 2018, Clinical and translational radiation oncology.

[4]  K. Patel,et al.  Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  M. Mehta,et al.  Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials. , 2017, International journal of radiation oncology, biology, physics.

[6]  Radhe Mohan,et al.  Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  C. Leemans,et al.  Individual patient information to select patients for different radiation techniques. , 2016, European journal of cancer.

[8]  J. Debus,et al.  Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma , 2016, Strahlentherapie und Onkologie.

[9]  Tsair-Fwu Lee,et al.  Predicting grade 2 acute radiation-induced dermatitis after hybrid intensity modulation radiotherapy for breast cancer using a logistic regression normal tissue complication probability model , 2016 .

[10]  Johannes A Langendijk,et al.  The Quest for Evidence for Proton Therapy: Model-Based Approach and Precision Medicine. , 2016, International journal of radiation oncology, biology, physics.

[11]  Mechthild Krause,et al.  Radiation oncology in the era of precision medicine , 2016, Nature Reviews Cancer.

[12]  E. Kasper,et al.  Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy , 2015, Radiation Oncology.

[13]  P. Nilsson,et al.  Comparative Proton and Photon Treatment Planning in Pediatric Patients with Various Diagnoses , 2015 .

[14]  Tsair-Fwu Lee,et al.  Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy , 2015, Radiation oncology.

[15]  W. Curry,et al.  Proton therapy for low‐grade gliomas: Results from a prospective trial , 2015, Cancer.

[16]  J. Habrand,et al.  Use of gEUD for predicting ear and pituitary gland damage following proton and photon radiation therapy. , 2015, The British journal of radiology.

[17]  Gaetano Rocco,et al.  Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  P. Brown,et al.  Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes. , 2014, International journal of radiation oncology, biology, physics.

[19]  Johannes A Langendijk,et al.  Development of a multivariable normal tissue complication probability (NTCP) model for tube feeding dependence after curative radiotherapy/chemo-radiotherapy in head and neck cancer. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Amy P Abernethy,et al.  Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). , 2014, Journal of the National Cancer Institute.

[21]  Oliver Jäkel,et al.  Proton and carbon ion radiotherapy for primary brain tumors and tumors of the skull base , 2013, Acta oncologica.

[22]  S. Khatua,et al.  Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma. , 2013, International journal of radiation oncology, biology, physics.

[23]  Johannes A Langendijk,et al.  Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  Jürgen Debus,et al.  First experiences in treatment of low-grade glioma grade I and II with proton therapy , 2012, Radiation oncology.

[25]  Johannes A Langendijk,et al.  Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  Johannes A Langendijk,et al.  NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  O. Erol,et al.  Effects of alopecia on body image and quality of life of Turkish cancer women with or without headscarf , 2012, Supportive Care in Cancer.

[28]  D. Kwong,et al.  Dosimetric predictors of radiation-induced acute nausea and vomiting in IMRT for nasopharyngeal cancer. , 2012, International journal of radiation oncology, biology, physics.

[29]  K. Harrington,et al.  Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  M. Mehta,et al.  Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. , 2012, International journal of radiation oncology, biology, physics.

[31]  G. Goitein,et al.  Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute. , 2012, International journal of radiation oncology, biology, physics.

[32]  J. Hannoun-Lévi,et al.  Dose de tolérance des tissus sains : la peau et les phanères , 2010 .

[33]  Adam P Dicker,et al.  Radiation dose-volume effects in the brain. , 2010, International journal of radiation oncology, biology, physics.

[34]  J. Cox,et al.  Comparison of surface doses from spot scanning and passively scattered proton therapy beams , 2009, Physics in medicine and biology.

[35]  Randall K Ten Haken,et al.  Parotid gland function after radiotherapy: the combined michigan and utrecht experience. , 2008, International journal of radiation oncology, biology, physics.

[36]  Å. Palm,et al.  A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors , 2007, Acta oncologica.

[37]  A. Niemierko,et al.  Permanent alopecia after cranial irradiation: dose-response relationship. , 2004, International journal of radiation oncology, biology, physics.

[38]  C. Miaskowski.  Gender differences in pain, fatigue, and depression in patients with cancer. , 2004, Journal of the National Cancer Institute. Monographs.

[39]  J. Horiot,et al.  Treatment implications for radiation-induced nausea and vomiting in specific patient groups. , 2004, European journal of cancer.

[40]  C. Divino,et al.  Wound Care After Radiation Therapy , 2002, Advances in skin & wound care.

[41]  David Khayat,et al.  Changing patient perceptions of the side effects of cancer chemotherapy , 2002, Cancer.

[42]  D. Finkelstein,et al.  Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. , 2001, International journal of radiation oncology, biology, physics.

[43]  A. Finlay,et al.  The effect of hair loss on quality of life , 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.

[44]  J. Buatti,et al.  Calculation of cranial nerve complication probability for acoustic neuroma radiosurgery. , 2000, International journal of radiation oncology, biology, physics.

[45]  S. Zhou,et al.  Conformal radiation therapy treatment planning reduces the dose to the optic structures for patients with tumors of the paranasal sinuses. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[46]  D. Osoba,et al.  Fatigue in patients with cancer: results with National Cancer Institute of Canada Clinical Trials Group studies employing the EORTC QLQ-C30 , 1997, Supportive Care in Cancer.

[47]  M. Martel,et al.  Dose-volume complication analysis for visual pathway structures of patients with advanced paranasal sinus tumors. , 1997, International journal of radiation oncology, biology, physics.

[48]  M. Goitein,et al.  Fitting of normal tissue tolerance data to an analytic function. , 1991, International journal of radiation oncology, biology, physics.

[49]  C. Scott,et al.  Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. , 2000, International journal of radiation oncology, biology, physics.